KLK3 and Familial prostate cancer: In light of the United Service Preventative Task Force recommendation against the use of prostate specific antigen (PSA) for cancer screening, as well as several studies demonstrating no survival advantage with aggressive treatment, there has been a growing interest in the use of active surveillance in prostate cancer management (3).